Odisha-based deep-tech startup Coratia Technologies has raised INR 5 crore (around $563,000) in a funding round led by Piper Serica Angel Fund.
The company plans to use the new funds to strengthen research and development, boost production, enhance existing products, and expand into international markets.
Earlier, in July 2025, its existing investors MGF Kavachh and Pontaq Ventures had jointly invested over ₹17 crore to support India’s goal of becoming self-reliant in underwater and subsea robotics.
The new funding follows Coratia’s recent ₹66 crore contract with the Indian Navy for its locally developed Underwater Remotely Operated Vehicle (UWROV) called Jalasimha.
Coratia Technologies was founded in 2021 by Debendra Pradhan and Biswajit Swain. It is a deep-tech startup based in Odisha that builds advanced underwater robots.
These robots are designed for both defence and civilian applications, helping in underwater exploration, inspection, and operations.
The company’s main products — Jalasimha, Jaladuta, Oceanus, and Navya — are built to serve both military and commercial needs.
Debendra Pradhan, Co-Founder & CEO, Coratia Technologies, said, “This investment goes a long way to support our vision to transform underwater robotics and strengthen India’s position within the global blue economy. We are building a global supply chain from India. Our focus remains on developing and exporting indigenously developed capabilities that serve both strategic and commercial needs across friendly markets.”
Biswajit Swain, Co-Founder & CTO, Coratia Technologies, said, “We’re building systems that redefine operational efficiency and reliability under extreme environments at a fraction of the cost globally.”
Ajay Modi, Director of Investments, Piper Serica, said, “We’re proud to back Coratia as it redefines underwater robotics and accelerates India’s rise as a technology powerhouse by 2030. Debendra and Biswajit have built an exceptional technological moat and the landmark Navy order is powerful proof of Coratia’s potential. The company is poised for rapid growth.”
Read more- Rage Biotech AU$29 million Series A round led by IP Group Australia
